These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 30064138

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    Zhang J, Chong CC, Chen GG, Lai PB.
    PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 5. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P, Wen DY, Li Q, He Y, Yang H, Chen G.
    Cell Physiol Biochem; 2018 Sep 22; 48(5):1953-1967. PubMed ID: 30092571
    [Abstract] [Full Text] [Related]

  • 6. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X, Ma L, Zhai L, Chen D, Li Y, Shang Z, Zhang Z, Gao Y, Yang W, Li Y, Pan Y.
    Int J Med Sci; 2021 Sep 22; 18(4):984-999. PubMed ID: 33456356
    [Abstract] [Full Text] [Related]

  • 7. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.
    Salvi A, Abeni E, Portolani N, Barlati S, De Petro G.
    Int J Oncol; 2013 Feb 22; 42(2):391-402. PubMed ID: 23229173
    [Abstract] [Full Text] [Related]

  • 8. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
    Zhang R, Jiang YY, Xiao K, Huang XQ, Wang J, Chen SY.
    J Cancer Res Clin Oncol; 2020 Jan 22; 146(1):87-96. PubMed ID: 31758243
    [Abstract] [Full Text] [Related]

  • 9. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB, Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, Chang JPE, Tan CK, Lee CGL.
    Sci Rep; 2019 Jul 18; 9(1):10464. PubMed ID: 31320713
    [Abstract] [Full Text] [Related]

  • 10. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    Fornari F, Ferracin M, Trerè D, Milazzo M, Marinelli S, Galassi M, Venerandi L, Pollutri D, Patrizi C, Borghi A, Foschi FG, Stefanini GF, Negrini M, Bolondi L, Gramantieri L.
    PLoS One; 2015 Jul 18; 10(10):e0141448. PubMed ID: 26509672
    [Abstract] [Full Text] [Related]

  • 11. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M, Hu W, Xiong CL, Qu Z, Yin CQ, Wang YH, Luo CL, Guan Q, Yuan CH, Wang FB.
    Oncotarget; 2016 Dec 06; 7(49):80751-80764. PubMed ID: 27811373
    [Abstract] [Full Text] [Related]

  • 12. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y, Wen DY, Zhang R, Huang JC, Lin P, Ren FH, Wang X, He Y, Yang H, Chen G, Luo DZ.
    Cell Physiol Biochem; 2018 Dec 06; 47(6):2216-2232. PubMed ID: 29975928
    [Abstract] [Full Text] [Related]

  • 13. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH.
    Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924
    [Abstract] [Full Text] [Related]

  • 14. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M, Kong X, Wang H, Huang G, Ye C, He Z.
    Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739
    [Abstract] [Full Text] [Related]

  • 15. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.
    Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD.
    Clin Cancer Res; 2008 Jan 15; 14(2):419-27. PubMed ID: 18223217
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS, Yu W, Cui H, Wang YJ, Zhang L, Han F, Huang T.
    Int J Clin Exp Pathol; 2015 Jan 15; 8(6):7234-8. PubMed ID: 26261620
    [Abstract] [Full Text] [Related]

  • 17. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
    Giannini E, Risso D, Botta F, Romagnoli P, Malfatti F, Fumagalli A, Testa E, Podestà E, Chiarbonello B, Polegato S, Testa R.
    J Intern Med; 2004 Mar 15; 255(3):399-408. PubMed ID: 14871465
    [Abstract] [Full Text] [Related]

  • 18. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX, Zhang BL, Yang Y, Wang MC, Lei GL, Gao Y, Liu H, Xiao CH, Xu JJ, Qin H, Xu XY, Chen ZS, Zhang DD, Li FG, Zhang SG, Liu R.
    Oncol Rep; 2019 Jan 15; 41(1):257-269. PubMed ID: 30542726
    [Abstract] [Full Text] [Related]

  • 19. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
    Wojcicka A, Swierniak M, Kornasiewicz O, Gierlikowski W, Maciag M, Kolanowska M, Kotlarek M, Gornicka B, Koperski L, Niewinski G, Krawczyk M, Jazdzewski K.
    Int J Biochem Cell Biol; 2014 Aug 15; 53():208-17. PubMed ID: 24875649
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH.
    World J Gastroenterol; 2019 Nov 14; 25(42):6322-6341. PubMed ID: 31754293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.